{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:34:55Z","timestamp":1785458095263,"version":"3.56.0"},"reference-count":32,"publisher":"Pacini Editore","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Otorhinolaryngol Ital"],"DOI":"10.14639\/0392-100x-2307","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T11:57:50Z","timestamp":1558958270000},"page":"156-161","source":"Crossref","is-referenced-by-count":35,"title":["Repeatedly recurring pleomorphic adenoma: a therapeutic challenge","Adenoma pleomorfo plurirecidivante: una sfida terapeutica"],"prefix":"10.14639","volume":"39","author":[{"given":"K.","family":"Aro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tarkkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Atula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"20340","published-online":{"date-parts":[[2019,6]]},"reference":[{"key":"10.14639\/0392-100X-2307_ref1","doi-asserted-by":"crossref","unstructured":"Valstar MH, de Ridder M, van den Broek EC, et al. Salivary gland pleomorphic adenoma in the Netherlands: a nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence. Oral Oncol 2017;66:93-9.","DOI":"10.1016\/j.oraloncology.2017.01.004"},{"key":"10.14639\/0392-100X-2307_ref2","doi-asserted-by":"crossref","unstructured":"Andreasen S, Therkildsen MH, Bjorndal K, et al. Pleomorphic adenoma of the parotid gland 1985-2010: a Danish nationwide study of incidence, recurrence rate, and malignant transformation. Head Neck 2016;38(Suppl 1):1364-9.","DOI":"10.1002\/hed.24228"},{"key":"10.14639\/0392-100X-2307_ref3","doi-asserted-by":"crossref","unstructured":"Zbaren P, Vander Poorten V, Witt RL, et al. Pleomorphic adenoma of the parotid: formal parotidectomy or limited surgery? Am J Surg 2013;205:109-18.","DOI":"10.1016\/j.amjsurg.2012.05.026"},{"key":"10.14639\/0392-100X-2307_ref4","doi-asserted-by":"crossref","unstructured":"Park GC, Cho KJ, Kang J, et al. Relationship between histopathology of pleomorphic adenoma in the parotid gland and recurrence after superficial parotidectomy. J Surg Oncol 2012;106:942-6.","DOI":"10.1002\/jso.23202"},{"key":"10.14639\/0392-100X-2307_ref5","doi-asserted-by":"crossref","unstructured":"Riad MA, Abdel-Rahman H, Ezzat WF, et al. Variables related to recurrence of pleomorphic adenomas: outcome of parotid surgery in 182 cases. Laryngoscope 2011;121:1467-72.","DOI":"10.1002\/lary.21830"},{"key":"10.14639\/0392-100X-2307_ref6","doi-asserted-by":"crossref","unstructured":"Witt RL. The significance of the margin in parotid surgery for pleomorphic adenoma. Laryngoscope 2002;112:2141-54.","DOI":"10.1097\/00005537-200212000-00004"},{"key":"10.14639\/0392-100X-2307_ref7","doi-asserted-by":"crossref","unstructured":"Zbaren P, Tschumi I, Nuyens M, et al. Recurrent pleomorphic adenoma of the parotid gland. Am J Surg 2005;189:203-7.","DOI":"10.1016\/j.amjsurg.2004.11.008"},{"key":"10.14639\/0392-100X-2307_ref8","doi-asserted-by":"crossref","unstructured":"Wittekindt C, Streubel K, Arnold G, et al. Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients. Head Neck 2007;29:822-8.","DOI":"10.1002\/hed.20613"},{"key":"10.14639\/0392-100X-2307_ref9","doi-asserted-by":"crossref","unstructured":"Redaelli de Zinis LO, Piccioni M, Antonelli AR, et al. Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature. Eur Arch Otorhinolaryngol 2008;265:447-52.","DOI":"10.1007\/s00405-007-0502-y"},{"key":"10.14639\/0392-100X-2307_ref10","doi-asserted-by":"crossref","unstructured":"Colella G, Cannavale R, Chiodini P. Meta-analysis of surgical approaches to the treatment of parotid pleomorphic adenomas and recurrence rates. J Craniomaxillofac Surg 2015;43:738-45.","DOI":"10.1016\/j.jcms.2015.03.017"},{"key":"10.14639\/0392-100X-2307_ref11","doi-asserted-by":"crossref","unstructured":"Foresta E, Torroni A, Di Nardo F, et al. Pleomorphic adenoma and benign parotid tumors: extracapsular dissection vs superficial parotidectomy - review of literature and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;117:663-76.","DOI":"10.1016\/j.oooo.2014.02.026"},{"key":"10.14639\/0392-100X-2307_ref12","doi-asserted-by":"crossref","unstructured":"Zbaren P, Stauffer E. Pleomorphic adenoma of the parotid gland: histopathologic analysis of the capsular characteristics of 218 tumors. Head Neck 2007;29:751-7.","DOI":"10.1002\/hed.20569"},{"key":"10.14639\/0392-100X-2307_ref13","doi-asserted-by":"crossref","unstructured":"Espinosa CA, Fernandez-Valle A, Lequerica-Fernandez P, et al. Clinicopathologic and surgical study of pleomorphic adenoma of the parotid gland: analysis of risk factors for recurrence and facial nerve dysfunction. J Oral Maxillofac Surg 2018;76:347-54.","DOI":"10.1016\/j.joms.2017.07.171"},{"key":"10.14639\/0392-100X-2307_ref14","doi-asserted-by":"crossref","unstructured":"Witt RL, Eisele DW, Morton RP, et al. Etiology and management of recurrent parotid pleomorphic adenoma. Laryngoscope 2015;125:888-93.","DOI":"10.1002\/lary.24964"},{"key":"10.14639\/0392-100X-2307_ref15","doi-asserted-by":"crossref","unstructured":"Christensen RK, Bjorndal K, Godballe C, et al. Value of fine-needle aspiration biopsy of salivary gland lesions. Head Neck 2010;32:104-8.","DOI":"10.1002\/hed.21151"},{"key":"10.14639\/0392-100X-2307_ref16","doi-asserted-by":"crossref","unstructured":"Heaton CM, Chazen JL, van Zante A, et al. Pleomorphic adenoma of the major salivary glands: diagnostic utility of FNAB and MRI. Laryngoscope 2013;123:3056-60.","DOI":"10.1002\/lary.24247"},{"key":"10.14639\/0392-100X-2307_ref17","doi-asserted-by":"crossref","unstructured":"Atula T, Panigrahi J, Tarkkanen J, et al. Preoperative evaluation and surgical planning of submandibular gland tumors. Head Neck 2017;39:1071-7.","DOI":"10.1002\/hed.24691"},{"key":"10.14639\/0392-100X-2307_ref18","doi-asserted-by":"crossref","unstructured":"Zbaren P, Zbaren S, Caversaccio MD, et al. Carcinoma ex pleomorphic adenoma: diagnostic difficulty and outcome. Otolaryngol Head Neck Surg 2008;138:601-5.","DOI":"10.1016\/j.otohns.2008.01.013"},{"key":"10.14639\/0392-100X-2307_ref19","doi-asserted-by":"crossref","unstructured":"Natvig K, Soberg R. Relationship of intraoperative rupture of pleomorphic adenomas to recurrence: an 11-25 year follow-up study. Head Neck 1994;16:213-7.","DOI":"10.1002\/hed.2880160302"},{"key":"10.14639\/0392-100X-2307_ref20","doi-asserted-by":"crossref","unstructured":"Dell\u2019Aversana Orabona G, Bonavolonta P, Iaconetta G, et al. Surgical management of benign tumors of the parotid gland: extracapsular dissection versus superficial parotidectomy - our experience in 232 cases. J Oral Maxillofac Surg 2013;71:410-3.","DOI":"10.1016\/j.joms.2012.05.003"},{"key":"10.14639\/0392-100X-2307_ref21","doi-asserted-by":"crossref","unstructured":"Suh MW, Hah JH, Kwon SK, et al. Clinical manifestations of recurrent parotid pleomorphic adenoma. Clin Exp Otorhinolaryngol 2009;2:193-7.","DOI":"10.3342\/ceo.2009.2.4.193"},{"key":"10.14639\/0392-100X-2307_ref22","doi-asserted-by":"crossref","unstructured":"Li C, Xu Y, Zhang C, et al. Modified partial superficial parotidectomy versus conventional superficial parotidectomy improves treatment of pleomorphic adenoma of the parotid gland. Am J Surg 2014;208:112-8.","DOI":"10.1016\/j.amjsurg.2013.08.036"},{"key":"10.14639\/0392-100X-2307_ref23","doi-asserted-by":"crossref","unstructured":"Dulguerov P, Todic J, Pusztaszeri M, et al. Why do parotid pleomorphic adenomas recur? A systematic review of pathological and surgical variables. Front Surg 2017;4:26.","DOI":"10.3389\/fsurg.2017.00026"},{"key":"10.14639\/0392-100X-2307_ref24","doi-asserted-by":"crossref","unstructured":"Glikson E, Sagiv D, Mansour J, et al. Recurrent pleomorphic adenoma: is treatment considerably delayed thus affecting surgical morbidity? Acta Otolaryngol 2018;138:407-10.","DOI":"10.1080\/00016489.2017.1398840"},{"key":"10.14639\/0392-100X-2307_ref25","doi-asserted-by":"crossref","unstructured":"Ruohoalho J, Makitie AA, Aro K, et al. Complications after surgery for benign parotid gland neoplasms: a prospective cohort study. Head Neck 2017;39:170-6.","DOI":"10.1002\/hed.24496"},{"key":"10.14639\/0392-100X-2307_ref26","doi-asserted-by":"crossref","unstructured":"Carta F, Chuchueva N, Gerosa C, et al. Parotid tumours: clinical and oncologic outcomes after microscope-assisted parotidectomy with intraoperative nerve monitoring. Acta Otorhinolaryngol Ital 2017;37:375-86.","DOI":"10.14639\/0392-100X-1089"},{"key":"10.14639\/0392-100X-2307_ref27","doi-asserted-by":"crossref","unstructured":"Bradley PJ. The recurrent pleomorphic adenoma conundrum. Curr Opin Otolaryngol Head Neck Surg 2018;26:134-41.","DOI":"10.1097\/MOO.0000000000000435"},{"key":"10.14639\/0392-100X-2307_ref28","doi-asserted-by":"crossref","unstructured":"Becelli R, Morello R, Renzi G, et al. Recurrent pleomorphic adenoma of the parotid gland: role of neutron radiation therapy. J Craniofac Surg 2012;23:e449-50.","DOI":"10.1097\/SCS.0b013e318262d291"},{"key":"10.14639\/0392-100X-2307_ref29","doi-asserted-by":"crossref","unstructured":"Patel S, Mourad WF, Wang C, et al. Postoperative radiation therapy for parotid pleomorphic adenoma with close or positive margins: treatment outcomes and toxicities. Anticancer Res 2014;34:4247-51.","DOI":"10.1016\/j.ijrobp.2014.05.1654"},{"key":"10.14639\/0392-100X-2307_ref30","doi-asserted-by":"crossref","unstructured":"Wallace AS, Morris CG, Kirwan JM, et al. Radiotherapy for pleomorphic adenoma. Am J Otolaryngol 2013;34:36-40.","DOI":"10.1016\/j.amjoto.2012.08.002"},{"key":"10.14639\/0392-100X-2307_ref31","doi-asserted-by":"crossref","unstructured":"Douglas JG, Einck J, Austin-Seymour M, et al. Neutron radiotherapy for recurrent pleomorphic adenomas of major salivary glands. Head Neck 2001;23:1037-42.","DOI":"10.1002\/hed.10027"},{"key":"10.14639\/0392-100X-2307_ref32","doi-asserted-by":"crossref","unstructured":"Abu-Ghanem Y, Mizrachi A, Popovtzer A, et al. Recurrent pleomorphic adenoma of the parotid gland: institutional experience and review of the literature. J Surg Oncol 2016;114:714-8.","DOI":"10.1002\/jso.24392"}],"container-title":["Acta Otorhinolaryngologica Italica"],"original-title":[],"link":[{"URL":"https:\/\/www.actaitalica.it\/article\/view\/319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T07:13:50Z","timestamp":1729667630000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.actaitalica.it\/article\/view\/319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,6]]}},"URL":"https:\/\/doi.org\/10.14639\/0392-100x-2307","relation":{},"ISSN":["1827-675X"],"issn-type":[{"value":"1827-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]},"article-number":"4"}}